This website is intended for healthcare professionals

Ritlecitinib

First ever NHS drug to treat alopecia could be a ‘monumental day’ for severe hair loss sufferers

Ritlecitinib, a medication to treat people with severe hair loss has been recommended for NHS use for the first time

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP